期刊文献+

鞘内注射米诺环素对皮肤/肌肉切口和牵拉术后持续性痛大鼠机械缩足反射阈值的影响 被引量:2

Effects of intrathecal minocycline on MWT in a rat model of SMIR-evoked persistent postoperative pain
原文传递
导出
摘要 目的研究鞘内注射小胶质细胞活化特异性抑制剂米诺环素对皮肤/肌肉切口和牵拉(skin/muscle incision and retraction,SMIR)术后持续性痛大鼠机械缩足反射阈值(mechanical withdrawal threshold,MWT)的影响。方法选择鞘内置管成功的雄性SD大鼠32只,按随机数字表随机分为4组(每组8只):正常对照组、假手术组、SMIR模型组和SMIR模型±米诺环素组(简称米诺环素组)。按Yaksh法鞘内置管;按Flatters法制作大鼠SMIR术后持续性痛模型;应用vonFrey纤维细丝法测定MWT来评定疼痛行为学变化。结果与术前基础值和正常对照组比较,假手术组各时间点的MWT均无明显变化(术前基础值为13.0±0.9,正常对照组和假手术组在术前及术后第1、3,7、12、22、32天的MWT分别为13.2±0.9和13.0±0.9,13.2±0.7和12.9±1.0,12.9±0.8和12.7±1.1,12.8±1.2和13.0±1.0,13.3±0.7和13.2±1.0,12.8±0.8和12.9±1.2,12.9±1.1和13.1±0.8,P〉0.05);与术前基础值和假手术组相应时间点比较,SMIR模型组在术后第3、7、12、22天的MWT均明显下降(术前基础值为13.1±0.8,假手术组和SMIR模型组在术后第3、7、12、22天的MWT分别为12.7±1.1和9.1±0.3,13.0±1.0和7.8±1.0,13.2±1.0和5.4±1.0,12.9±1.2和9.0±0.4。P〈0.05);与SMIR模型组相应时间点比较,米诺环素组在术后第3、7、12、22天的MWT明显增加(SMIR模型组和米诺环素组术后第3、7、12、22天的MWT分别为9.1±0.3和10.8±1.3,7.8±1.0和8.9±0.1,5.4±1.0和8.0±1.1,9.0±0.4和9.9±0.7,P〈0.05)。结论在大鼠SMIR术后持续性痛模型中,鞘内注射米诺环素可明显减轻SMIR引起的疼痛行为学变化,提示脊髓小胶质细胞的活化在术后持续性痛发生和发展中具有重要作用。 objective To observe the effects of intrathecal minocycline (a selective inhibitor of microglia activation) on mechanical withdrawal threshold (MWT) in a rat model of persistent postoperative pain evoked by skin/muscle incision and retraction (SMIR). Methods 32 male Sprague-Dawley rats were randomly divided into four groups according to random number table (n=8): normal control group, sham operation group, SMIR model group and SMIR model plus intrathecal minocycline group (minocycline group). A PE-10 catheter was inserted into the subarachnoid space(intrathecal) according to the method described by Yaksh et al. A rat model of persistent postoperative pain evoked by SMIR was made according to the method described by Flatters. Pain behavior was assessed by MWT to von Frey filament stimulation intensity. Results Compared with both preoperative baseline and normal control group, the MWT of sham operation group did not change significantly at each time point (preoperative baseline: 13.0±0.9, the MWT of normal control group and sham operation group before operation and at postoperative days 1, 3, 7, 12, 22 and 32 were 13.2±0.9 and 13.0±0.9, 13.2±0.7 and 12.9±1.0, 12.9±0.8 and 12.7±1.1, 12.8±1.2 and 13.0±1.0, 13.3±0.7 and 13.2±1.0, 12.8±0.8 and 12.9±1.2, 12.9±1.1 and 13.1±0.8, respectively, P〉0.05). However, compared with both preoperative baseline and sham operation group, the MWT of SMIR model group decreased significantly at postoperative days 3, 7, 12 and 22 (preoperative baseline: 13.1±0.8, the MWT of sham operation group and SMIR model group at postoperative days 3, 7, 12 and 22 were 12.7±1.1 and 9.1±0.3, 13.0±1.0 and 7.8±1.0, 13.2±1.0 and 5,4±1.0, 12.9±1.2 and 9.0±0.4, respectively, P〈0.05); Compared with SMIR model group, the MWT of minocycline group increased significantly at postoperative days 3, 7, 12 and 22 (the MWT of SMIR model group and minocyeline group at postoperative (lays 3, 7, 12 and 22 were 9.1±0.3 and 10.8±1.3, 7.8±1.0 and 8.9±0.1, 5.4±1.0 and 8.0±1.1, 9.0±0.4 and 9.9 ±0.7, respectively, P〈0.05). Conclusion Intratheeal minocyeline markedly attenuates pain symptoms in a rat model of persistent postoperative pain evoked by SMIR, which suggests development and maintenance of persistent postoperative pain.
出处 《国际麻醉学与复苏杂志》 CAS 2011年第4期429-432,共4页 International Journal of Anesthesiology and Resuscitation
基金 湖南省科技计划一般项目资助课题(2009SK3018)
关键词 术后持续性痛 脊髓 小胶质细胞 米诺环素 Persistent postoperative pain Spinal cord that activated spinal microglia plays an important role in the Microglia Minocycline
  • 相关文献

参考文献9

  • 1Flatters SJ. Characterization of a model of persistent postoperative pain evoked by skin/muscle incision and retraction (SMIR). Pain, 2008, 135(1-2): 119-130.
  • 2Tan AM, Zhao P, Waxman SG, et al. Early microglial inhibition preemptively mitigates chronic pain development after experimental spinal cord injury. J Rehabil Res Dev, 2009, 46( 1 ): 123-133.
  • 3Hald A, Nedergaard S, Hansen RR, et al. Difterential activation of spinal cord glial cells in murine models of neuropathic and cancer pain. Eur J Pain, 2009, 13(2): 138-145.
  • 4Meller ST, Dykstra C, Grzybycki D, et al. The possible role of glia in nociceptive processing and hyperalgesia in the spinal-cord of the rat. Neuropharmacology, 1994, 33( 11 ) : 1471-1478.
  • 5Raghavendra V, Tanga F, DeLeo JA. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmaeol Exp Ther, 2003, 306(2): 624-630.
  • 6Yaksh TL, Rudy TA. Chronic catheterization of the spinal subarachnoid space. Physiol Behav, 1976, 17(6): 1031-1036.
  • 7Chaplan SR, Bach FW, Pogrel JW, et al. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods, 1994, 53 (1): 55-63.
  • 8张先红,申文,王明德,曾因明.鞘内注射胶质细胞抑制剂对CCD大鼠脊髓星形胶质细胞的影响[J].医学临床研究,2008,25(11):1925-1927. 被引量:3
  • 9Cao H, Zhang YQ. Spinal glial activation contributes to pathological pain states. Neurosci Biobehav Rev, 2008, 32(5): 972-983.

二级参考文献10

  • 1周占松,杨忠,李龙坤,宋波.脊髓小胶质细胞活化状态与前列腺的炎性疼痛[J].中国临床康复,2006,10(16):104-106. 被引量:4
  • 2Q. Zhang, P. G Haydon. Roles for gliotransmission in the nervous system[J]. J Neural Transm ,2004,3:19.
  • 3S. Vasce, P . Bezzi, A Volterra. The active role of astrocytes in synaptic transmission[J]. CMLS , 1998,56 : 991-1000.
  • 4Mako to Tsuda . Kazuhide Inoue and Michael W . salter. Neuropathic pain.and spinal mieroglia: a big problem from molecules in ‘small' glia[J]. TRENDS in Neurosciencrs , 2005,2. 28: 101-107.
  • 5Yaksh TL. Chronic catheterization of the spinal subarachnoid space[J]. Phusiol Behav , 1976,17: 1031-1036.
  • 6Ping Song,Zhi-Qi Zhao. The involvement of glia cell inthe development of morphine tolerance [ J ]. Neuroscience Reseach ,2001,39: 281-286.
  • 7Watkins LR, Milligan ED, Maier SF. Glial activation a driving force for pathological pain[J]. Trends Neurosci ,2001, 24(8) :450-455.
  • 8Watkins LR, Martin D Ulrich,P et al. Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat[J]. Pain , 1997,71 : 225-235.
  • 9Julie Wieseler-Frank, Steven F , Maier, Linda R, Wathins. Gila activation and pathological pain[J]. Neurochemistry International , 2004,45 : 385-395.
  • 10胡三觉,邢俊玲.大鼠背根节慢性压迫对行为和电生理反应的影响[J].中国疼痛医学杂志,1997,3(3):158-165. 被引量:15

共引文献2

同被引文献33

  • 1杨建平,蒋豪.大鼠蛛网膜下腔埋管并长期留置操作的改进[J].中华麻醉学杂志,1993,13(2):110-112. 被引量:123
  • 2Deumens R, Steyaert A, Forget P, et al. Prevention of chronic postoperative pain: cellular, molecular, and clinical insights for mechanism-based treatment approaches[J]. Prog Neurobiol, 2013, 104: 1-37.
  • 3Flatters SJ. Characterization of a model of persistent postoperative pain evoked by skin/muscle incision and retraction (SMIR) [J]. Pain, 2008, 135(1-2): 119-130.
  • 4Chaplan SR, Bach FW, Pogrel JW, et al. Quantitative assessment of tactile allodynia in the rat paw [J]. J Neurosci Methods, 1994, 53(1): 55-63.
  • 5Wen YK, Tan PH, Cheng JK, et al. Microglia: a promising target for treating neuropathic and postoperative pain,and morphine tolerance[J]. J Formos Med Assoc, 2011, 110(8): 487-494.
  • 6Svensson CI, Brodin E. Spinal astrocytes in pain processing:non- neuronal cells as therapeutic targets [J]. Mol Interv, 2010, 10 (1): 25-38.
  • 7Aldskogius H, Kozlova EN. Microglia and neuropathic pain[J].CNS Neurol Disord Drug Targets, 2013, 12(6): 768-772.
  • 8Berg-Johnsen J, Paulsen RE, Fonnum F, et al. Changes in evoked potentials and amino acid content during fluorocitrate action studied in rat hippocampal cortex [J]. Exp Brain Res, 1993, 96 (2): 241-246.
  • 9Kuang X, Huang Y, Gu HF, et al. Effects of intrathecal epigallocatechin gallate,an inhibitor of Toll-like receptor 4,on chronic neuropathic pain in rats[J]. Eur J Pharmacol, 2012, 676 (1-3): 51-56.
  • 10Sorge RE, LaCroix-Fralish ML, Turtle AH, et al. Spinal cord Toll-like receptor 4 mediates inflammatory and neuropathic hypersensitivity in male but not female mice [J]. J Neurosci, 2011, 31(43): 15450-15454.

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部